SpaceX is poised to be the biggest IPO ever. Here are the top U.S. deals to date

SpaceX is reportedly preparing a Nasdaq IPO under ticker SPCX that could raise around $75 billion, which would far exceed Alibaba's $22 billion record. The article frames the deal as a potential catalyst for a sluggish IPO market and highlights continued investor appetite for AI and private-market growth stories, with OpenAI, Anthropic, and Cerebras also in focus. Broader implications are positive for capital markets sentiment, though the piece is mainly a market-sizing and comparison story rather than a direct company event.

Analysis

This is less about one company and more about a reset in the supply of public risk. A landmark SpaceX print would likely act as a liquidity sponge for late-stage private capital, forcing a re-mark across adjacent private names that have been priced off a scarce-public-comps regime; that is most relevant for META/AI, UBER-adjacent autonomy, and venture-backed software where investors have been anchoring to private rounds instead of public multiples. The second-order effect is a rotation from “private scarcity premium” into a more disciplined public-market framework, which tends to favor firms with visible monetization and punish those relying on perpetual optionality.

The biggest near-term beneficiaries are the platform names that can absorb a re-rating of innovation risk without needing fresh capital. META stands out because it has both the balance sheet and the AI narrative to be treated as a compounding incumbent rather than a speculative growth proxy; a successful mega-IPO helps validate the market’s willingness to fund compute-heavy, capex-intensive growth at scale. By contrast, BABA remains the clearest relative loser: if capital is flowing toward U.S. frontier-tech assets, non-U.S. internet platforms with slower growth and regulatory overhangs become even less defensible on valuation grounds.

For UBER, the key nuance is not the IPO itself but the implied normalization of autonomy funding. A marquee public listing for a robotics/space franchise can tighten the market’s tolerance for long-duration R&D bets, which could help UBER’s robotaxi optionality trade if public investors start underwriting autonomous transport as a real near-term category rather than a science project. That also creates pressure on smaller mobility and EV software peers to prove unit economics faster, with GM a conditional beneficiary only if investors rotate into operating leverage stories instead of pure disruption narratives.

The contrarian risk is that a record-sized IPO can become a local top for issuance appetite rather than a durable reopening. If the deal absorbs too much marginal risk capital or prices aggressively, secondary tech multiples can compress for 4-8 weeks as PMs fund the allocation and reduce beta elsewhere. That would hit the less differentiated names first: RDDT, SNAP, PINS, and parts of the private-cloud complex via sentiment, even if fundamentals are unchanged.

Key Decisions for Investors

• Long META vs short BABA over the next 1-3 months: favor the self-funded AI compounder over the slower-growth global internet laggard; target re-rating divergence if IPO enthusiasm broadens but foreign tech stays under-owned.
• Add UBER on dips into the IPO window, 6-12 week horizon: use the market’s renewed willingness to fund autonomy/robotics as a catalyst for multiple support; risk is a broad post-IPO tech de-risking, so size modestly.
• Sell RDDT/SNAP/PINS against a basket of AI/mega-cap winners for 2-6 weeks: these names are most exposed to issuance-driven factor rotation and crowding unwind if investors fund new deals by trimming speculative growth.
• Keep GM as a tactical long only if the tape shifts toward industrial-operating leverage, not disruption beta; otherwise fade rallies because any benefit from renewed AV interest should be slower than the capitalization of the IPO event.
• If SPCX lists, consider a short-lived relative-value short in high-multiple private-tech proxies via public analogs rather than outright index shorts; the goal is to monetize valuation compression without taking full market beta.